GGrantIndex
← Leaderboards

Karsten Lunze

Boston Medical Center

$5,048,816
Attributed
$8,720,368
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY201625
$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,720,368 · 10

By mechanism

R01$3,462,782 · 2
R34$1,541,098 · 2
R61$1,471,876 · 1
R00$905,858 · 1
P30$671,252 · 1
K99$354,805 · 1

Most similar at Boston Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Participant

Research focus

ParticipantCaringCountryRandomizedPersonsInterviewSubstance UseEpidemicTrainingDrug UsageSocial StigmaAcquired Immunodeficiency SyndromeTransmission ProcessAddictionAffectAids PreventionSubstance Use DisorderPrimary OutcomeBehavior TherapyMedicalPreventPharmaceutical PreparationsAdherenceSeverities

Grant awards (25)

Development of Systems and Education for Cervical Cancer prevention (DOSE-CC)$753,446
R01 · FY2025 · CA · contact PI
Substance Use Prevention for Recently displaced Adults (SUPRA)$573,096
R61 · FY2025 · DA · contact PI
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"$447,321
R01 · FY2025 · AA
Sustaining recovery for people on opioid agonist treatment with conversational agents$263,151
R34 · FY2025 · DA · contact PI
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"$228,745
R01 · FY2025 · AA
Clinical Undergraduate Research in Addictions - Training and Experiences (CURATE) Program$134,697
R25 · FY2025 · DA · contact PI
Substance Use Prevention for Recently displaced Adults (SUPRA)$118,813
R61 · FY2025 · DA · contact PI
Substance Use Prevention for Recently displaced Adults (SUPRA)$779,967
R61 · FY2024 · DA · contact PI
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"$646,689
R01 · FY2024 · AA
Sustaining recovery for people on opioid agonist treatment with conversational agents$221,624
R34 · FY2024 · DA · contact PI
Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use$89,000
R03 · FY2024 · DA · contact PI
Preventing Mental Disorders Among Women Internally Displaced by War in Ukraine: The SHAWL Trial$740,235
R34 · FY2023 · MH · contact PI
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"$648,126
R01 · FY2023 · AA
Sustaining recovery for people on opioid agonist treatment with conversational agents$316,088
R34 · FY2023 · DA · contact PI
Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use$89,000
R03 · FY2023 · DA · contact PI
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"$738,455
R01 · FY2022 · AA
Core K - Substance Use Research Core$224,939
P30 · FY2022 · AI · contact PI
Core K - Substance Use Research Core$224,952
P30 · FY2021 · AI · contact PI
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs$248,722
R00 · FY2020 · DA · contact PI
Core K - Substance Use Research Core$221,361
P30 · FY2020 · AI · contact PI
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs$160,369
R00 · FY2020 · DA · contact PI
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs$247,823
R00 · FY2019 · DA · contact PI
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs$248,944
R00 · FY2018 · DA · contact PI
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs$177,370
K99 · FY2017 · DA · contact PI
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs$177,435
K99 · FY2016 · DA · contact PI